FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:760-761 August 14, 2008 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Zethelius, B. PubMed Citation

To the Editor: Zethelius et al. (May 15 issue)¹ suggest that the combination of multiple biomarkers with established risk factors results in an improved assessment of cardiovascular risk among elderly men. Unfortunately, they did not validate their findings in an independent cohort of patients.² Thus, a possibly spurious association they found in a highly selected subgroup may be erroneously generalized, particularly to women and to other age and ethnic groups. Why should we spend about 35 ($55) per patient to optimize our prognostic evaluation without having any proven effect on individual risk reduction? In contrast, simple and cheap risk scores . . . [Full Text of this Article]

This article has been cited by other articles:

• SHISHEHBOR, M. H., HAZEN, S. L. (2009). JUPITER to Earth: A statin helps people with normal LDL-C and high hs-CRP, but what does it mean?. Cleveland Clinic Journal of Medicine 76: 37-44 [Abstract] [Full Text]